to go to the previous page
Challenging Cases in the Management of Newly Diagnosed and Recurrent Prostate Cancer
Tuesday, November 2, 2010
Click the plus sign to see more detailed information
about each speaker.
, The Insitute of Cancer Research, Royal Marsden Hospital
Chief investigator of the MRC RADICALS trial of adjuvant treatment after radical prostatectomy.
UK principal investigator of the NCIC START trial of selective treatment against radical therapy.
Principal investigator of the Royal Marsden prospective cohort study of active surveillance of localised prostate cancer.
Member of the NICE Prostate Cancer Guideline Development Group.
Anthony V. D'Amico, M.D., Ph.D.
Christopher Kane, M.D.
Christopher R. King, M.D., Ph.D
Padraig Warde, M.B.Ch.B., B.A.O., F.R.C.P.C.
Audio Synchronized to PowerPoint